SCHEMBL19081765

SCHEMBL19081765

c1ccc(-c2c3ccccc3c(-c3ccc4c(c3)oc3ccc5c6ccc7ccccc7c6sc5c34)c3ccccc23)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 6/20 0.42
CYP1B1 Q16678 5/20 0.42
ABCG2 Q9UNQ0 7/20 0.39
CYP1A2 P05177 5/20 0.39
PAX8 Q06710 2/20 0.39
FYN P06241 1/20 0.39
MAPK3 P27361 1/20 0.39
AHR P35869 1/20 0.39
TDP1 Q9NUW8 4/20 0.34
MAPK1 P28482 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
KDM4E B2RXH2 2/20 0.34
MAPT P10636 2/20 0.34
HPGD P15428 2/20 0.34
TSHR P16473 2/20 0.34
HSD17B10 Q99714 2/20 0.34
PDE5A O76074 1/20 0.34
ALDH1A1 P00352 1/20 0.34
TP53 P04637 1/20 0.34
ABCB1 P08183 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081876 0.94 CYP1A1 (0.40) CYP1A1CYP1B1ABCG2CYP1A2PAX8
SCHEMBL19081862 0.92 CYP1A1 (0.38) CYP1A1CYP1B1ABCG2CYP1A2PAX8
SCHEMBL19081998 0.92 CYP1A1 (0.38) CYP1A1CYP1B1ABCG2CYP1A2PAX8
SCHEMBL19081929 0.87 CYP1A1 (0.36) CYP1A1CYP1B1CYP1A2AHRMAPT
SCHEMBL19081821 0.87 ABCG2 (0.40) CYP1A1CYP1B1ABCG2CYP1A2PAX8
SCHEMBL27287911 0.86 ABCG2 (0.39) CYP1A1CYP1B1ABCG2CYP1A2PAX8
SCHEMBL17945441 0.85 CYP1A1 (0.43) CYP1A1CYP1B1ABCG2CYP1A2PAX8
SCHEMBL15461366 0.85 ABCG2 (0.49) CYP1A1CYP1B1ABCG2CYP1A2PAX8
SCHEMBL19082019 0.85 CYP1A1 (0.38) CYP1A1CYP1B1ABCG2CYP1A2PAX8
SCHEMBL19081964 0.84 CYP1A1 (0.36) CYP1A1CYP1B1ABCG2CYP1A2PAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885ABCG2 4823/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885ABCG2 4823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.